BioLight Life Sciences Ltd. (TLV:BOLT)
Israel
· Delayed Price · Currency is ILS · Price in ILA 237.90
+2.40 (1.02%)
Apr 29, 2026, 11:05 AM IDT
BioLight Life Sciences Balance Sheet
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 3.98 | 9.72 | 5.28 | 13.39 | 33.47 | Upgrade
|
| Short-Term Investments | - | - | 0.25 | 1.25 | 0.25 | Upgrade
|
| Trading Asset Securities | 18.47 | 3.75 | 3.12 | 2.99 | - | Upgrade
|
| Cash & Short-Term Investments | 22.44 | 13.47 | 8.64 | 17.63 | 33.71 | Upgrade
|
| Cash Growth | 66.65% | 55.81% | -50.96% | -47.72% | -34.04% | Upgrade
|
| Other Receivables | - | - | - | - | 0 | Upgrade
|
| Receivables | - | - | - | - | 0 | Upgrade
|
| Prepaid Expenses | 0.44 | 0.44 | 0.07 | 0.09 | 0.04 | Upgrade
|
| Other Current Assets | 1.52 | 0.44 | 0.34 | 0.31 | 0.25 | Upgrade
|
| Total Current Assets | 24.4 | 14.35 | 9.06 | 18.02 | 34 | Upgrade
|
| Property, Plant & Equipment | 4.32 | 4.16 | 4.27 | 3.34 | 3.26 | Upgrade
|
| Long-Term Investments | 12.86 | 13.53 | 19.37 | 34.88 | 25.82 | Upgrade
|
| Other Intangible Assets | 0.69 | 0.69 | 0.69 | 0.69 | 0.15 | Upgrade
|
| Other Long-Term Assets | 0.15 | 1.4 | 0.07 | 0.09 | 0.95 | Upgrade
|
| Total Assets | 42.41 | 34.12 | 33.45 | 57.01 | 64.17 | Upgrade
|
| Accounts Payable | 0.08 | 0.13 | 0.24 | 0.3 | 0.15 | Upgrade
|
| Accrued Expenses | 1.39 | 1.4 | 1.51 | 1.71 | 1.62 | Upgrade
|
| Current Portion of Leases | 0.53 | 0.53 | 0.09 | 0.53 | 0.44 | Upgrade
|
| Current Unearned Revenue | - | - | 0.48 | - | - | Upgrade
|
| Total Current Liabilities | 2 | 2.07 | 2.32 | 2.54 | 2.21 | Upgrade
|
| Long-Term Leases | 0.24 | 0.07 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 1.06 | 1.25 | 0.84 | 0.78 | 0.54 | Upgrade
|
| Total Liabilities | 3.3 | 3.38 | 3.15 | 3.32 | 2.75 | Upgrade
|
| Common Stock | 22.62 | 11.65 | 11.65 | 11.44 | 11.4 | Upgrade
|
| Additional Paid-In Capital | 257.57 | 251.1 | 250.78 | 250.46 | 250.42 | Upgrade
|
| Retained Earnings | -261.69 | -249.97 | -242.82 | -216.8 | -208.96 | Upgrade
|
| Comprehensive Income & Other | 15.9 | 14.1 | 10.17 | 8.07 | 7.84 | Upgrade
|
| Total Common Equity | 34.4 | 26.88 | 29.78 | 53.17 | 60.7 | Upgrade
|
| Minority Interest | 4.71 | 3.86 | 0.53 | 0.52 | 0.72 | Upgrade
|
| Shareholders' Equity | 39.11 | 30.74 | 30.3 | 53.69 | 61.42 | Upgrade
|
| Total Liabilities & Equity | 42.41 | 34.12 | 33.45 | 57.01 | 64.17 | Upgrade
|
| Total Debt | 0.77 | 0.6 | 0.09 | 0.53 | 0.44 | Upgrade
|
| Net Cash (Debt) | 21.67 | 12.87 | 8.55 | 17.1 | 33.27 | Upgrade
|
| Net Cash Growth | 68.41% | 50.47% | -49.98% | -48.61% | -33.70% | Upgrade
|
| Net Cash Per Share | 3.66 | 2.76 | 1.84 | 3.74 | 7.25 | Upgrade
|
| Filing Date Shares Outstanding | 9.05 | 4.69 | 4.66 | 4.64 | 4.56 | Upgrade
|
| Total Common Shares Outstanding | 9.05 | 4.66 | 4.66 | 4.58 | 4.56 | Upgrade
|
| Working Capital | 22.4 | 12.28 | 6.74 | 15.49 | 31.79 | Upgrade
|
| Book Value Per Share | 3.80 | 5.77 | 6.39 | 11.62 | 13.31 | Upgrade
|
| Tangible Book Value | 33.72 | 26.19 | 29.09 | 52.48 | 60.55 | Upgrade
|
| Tangible Book Value Per Share | 3.73 | 5.62 | 6.25 | 11.47 | 13.28 | Upgrade
|
| Machinery | 0.56 | 0.56 | 0.64 | 0.64 | 0.54 | Upgrade
|
| Leasehold Improvements | - | - | 0.07 | 0.07 | 0.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.